Insider Transactions in Q1 2024 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
3,365
+15.14%
|
-
|
|
Mar 28
2024
|
Oren Gilad President/CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,725
+1.99%
|
-
|
|
Mar 13
2024
|
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
BUY
Open market or private purchase
|
Direct |
1,010
+6.12%
|
$7,070
$7.29 P/Share
|
|
Mar 13
2024
|
Oren Gilad President/CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.61%
|
$14,000
$7.29 P/Share
|
|
Mar 13
2024
|
John B Henneman Iii Director |
BUY
Open market or private purchase
|
Direct |
6,860
+45.74%
|
$48,020
$7.29 P/Share
|
|
Mar 13
2024
|
Bernd R. Seizinger Director |
BUY
Open market or private purchase
|
Direct |
6,860
+16.92%
|
$48,020
$7.29 P/Share
|